Finance

Lists
Why is VRCA down २.४३%?
Dive Deeper
VRCA:NASDAQ
Verrica Pharmaceuticals Inc
US$ ४.०१
-२.४३%
(-०.१००) 1D
US$ ४.०९
+२.००% (+०.०८०)
Pre-market
Closed: अक्टोबर १२, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VRCA...
Open
US$ ४.२०
High
US$ ४.२०
Low
US$ ४.००
Mkt. cap
६.८९ करोड
Avg. vol.
५९.९५ हजार
Volume
०.००
52-wk high
US$ ९.८२
52-wk low
US$ ३.२८
EPS
-US$ १.६७
Beta
१.६०
Shares outstanding
१.७२ करोड
No. of employees
७६
Open
US$ ४.२०
High
US$ ४.२०
Low
US$ ४.००
Mkt. cap
६.८९ करोड
Avg. vol.
५९.९५ हजार
Volume
०.००
52-wk high
US$ ९.८२
52-wk low
US$ ३.२८
EPS
-US$ १.६७
Beta
१.६०
Shares outstanding
१.७२ करोड
No. of employees
७६
News stories
From web sources and news partners
About Verrica Pharmaceuticals Inc
CEOJayson Rieger
Employees७६
Founded२०१३
HeadquartersWest Chester, पेन्सिलभेनिया, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to VRCA in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for VRCA in the last 3 months.
Highest
Current US$ ४.०१
US$ २०.०० (+३९८.७५%)
Average
US$ १३.६७ (+२४०.९०%)
Lowest
US$ ९.०० (+१२४.४४%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
US$ ९.००
+१२४.४%
10/01/2026
Serge Belanger
Needham
Hold
Maintained
-
-
08/27/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ १२.००
+१९९.३%
08/07/2026
Stacy Ku
TD Cowen
Buy
Reiterated
US$ २०.००
+३९८.८%
08/06/2026
Kemp Dolliver
Brookline Capital Markets
Buy
Upgraded
US$ १७.००
+३२३.९%
12/17/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.४३ करोड
५०.९२ लाख
५०.२३ लाख
५८.६२ लाख
Cost of goods sold
३३.१४ लाख
३९.२१ लाख
४७.४९ लाख
६९.१२ लाख
Cost of revenue
३३.१४ लाख
३९.२१ लाख
४७.४९ लाख
६९.१२ लाख
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
९४.०३ लाख
८१.१७ लाख
९९.८९ लाख
१.०३ करोड
Operating expense
९४.०३ लाख
८१.१७ लाख
९९.८९ लाख
१.०३ करोड
Total operating expenses
१.२७ करोड
१.२० करोड
१.४७ करोड
१.७३ करोड
Operating income
१६.२७ लाख
-६९.४६ लाख
-९७.१५ लाख
-१.१४ करोड
Other non operating income
३४.०० हजार
१७.६० लाख
-८.०० हजार
-३.०० हजार
EBT including unusual items
-२.७४ लाख
-८०.७४ लाख
-९६.८२ लाख
-१.३२ करोड
EBT excluding unusual items
-२.७४ लाख
-६२.९५ लाख
-९६.८२ लाख
-१.१५ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.७४ लाख
-८०.७४ लाख
-९६.८२ लाख
-१.३२ करोड
Net profit margin
-१.९१%
-१५८.५६%
-१९२.७५%
-२२४.३८%
Earnings per share
०.१३
-०.५१
-०.४५
-०.४८
Interest and investment income
१.५९ लाख
२.०५ लाख
२.०१ लाख
१.११ लाख
Interest expense
-२०.९४ लाख
-१३.१४ लाख
-१.६० लाख
-१.६४ लाख
Net interest expenses
-१९.३५ लाख
-११.०९ लाख
४१.०० हजार
-५३.०० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
१७.३७ लाख
-६८.३२ लाख
-९५.९८ लाख
-१.१३ करोड
Gain or loss from assets sale
६८.०० हजार
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू